Amphastar Pharmaceuticals, Inc. (AMPH)
USD 25.23
(-5.19%)
USD 25.23
(-5.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 589.19 Million USD | 510.36% |
| 2022 | 96.53 Million USD | -2.96% |
| 2021 | 99.47 Million USD | 92.6% |
| 2020 | 51.65 Million USD | -7.29% |
| 2019 | 55.7 Million USD | 74.18% |
| 2018 | 31.98 Million USD | -21.69% |
| 2017 | 40.84 Million USD | 26.23% |
| 2016 | 32.35 Million USD | 7.26% |
| 2015 | 30.16 Million USD | -16.45% |
| 2014 | 36.1 Million USD | 258.59% |
| 2013 | 10.06 Million USD | -36.87% |
| 2012 | 15.95 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 594 Million USD | 0.82% |
| 2024 Q2 | 586.85 Million USD | -1.2% |
| 2023 Q2 | 512.68 Million USD | 429.27% |
| 2023 Q4 | 589.19 Million USD | -11.85% |
| 2023 FY | 589.19 Million USD | 510.36% |
| 2023 Q1 | 96.86 Million USD | 0.34% |
| 2023 Q3 | 668.4 Million USD | 30.37% |
| 2022 Q4 | 96.53 Million USD | -1.87% |
| 2022 Q3 | 98.37 Million USD | -0.18% |
| 2022 FY | 96.53 Million USD | -2.96% |
| 2022 Q1 | 99.83 Million USD | 0.36% |
| 2022 Q2 | 98.55 Million USD | -1.29% |
| 2021 Q3 | 101.01 Million USD | 83.62% |
| 2021 Q2 | 55.01 Million USD | 12.74% |
| 2021 Q1 | 48.79 Million USD | -5.52% |
| 2021 FY | 99.47 Million USD | 92.6% |
| 2021 Q4 | 99.47 Million USD | -1.52% |
| 2020 Q2 | 49.15 Million USD | -4.82% |
| 2020 Q3 | 50.43 Million USD | 2.61% |
| 2020 Q4 | 51.65 Million USD | 2.4% |
| 2020 FY | 51.65 Million USD | -7.29% |
| 2020 Q1 | 51.64 Million USD | -7.3% |
| 2019 Q1 | 42.14 Million USD | 31.78% |
| 2019 FY | 55.7 Million USD | 74.18% |
| 2019 Q4 | 55.7 Million USD | 1.25% |
| 2019 Q3 | 55.01 Million USD | -4.39% |
| 2019 Q2 | 57.54 Million USD | 36.54% |
| 2018 Q1 | 39.7 Million USD | -2.79% |
| 2018 FY | 31.98 Million USD | -21.69% |
| 2018 Q4 | 31.98 Million USD | -1.91% |
| 2018 Q3 | 32.6 Million USD | -3.23% |
| 2018 Q2 | 33.69 Million USD | -15.14% |
| 2017 Q4 | 40.84 Million USD | -3.29% |
| 2017 FY | 40.84 Million USD | 26.23% |
| 2017 Q1 | 31.14 Million USD | -3.73% |
| 2017 Q2 | 40.1 Million USD | 28.76% |
| 2017 Q3 | 42.23 Million USD | 5.3% |
| 2016 Q1 | 29.09 Million USD | -3.56% |
| 2016 FY | 32.35 Million USD | 7.26% |
| 2016 Q4 | 32.35 Million USD | -5.29% |
| 2016 Q3 | 34.16 Million USD | 7.63% |
| 2016 Q2 | 31.74 Million USD | 9.11% |
| 2015 Q3 | 31.35 Million USD | -9.9% |
| 2015 Q2 | 34.79 Million USD | -3.03% |
| 2015 Q1 | 35.88 Million USD | -0.61% |
| 2015 FY | 30.16 Million USD | -16.45% |
| 2015 Q4 | 30.16 Million USD | -3.79% |
| 2014 Q4 | 36.1 Million USD | -12.51% |
| 2014 Q3 | 41.27 Million USD | -3.68% |
| 2014 Q2 | 42.85 Million USD | 345.8% |
| 2014 Q1 | 9.61 Million USD | -4.54% |
| 2014 FY | 36.1 Million USD | 258.59% |
| 2013 Q3 | 10.17 Million USD | 0.0% |
| 2013 Q4 | 10.06 Million USD | -1.01% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 10.06 Million USD | -36.87% |
| 2012 Q4 | 15.95 Million USD | 0.0% |
| 2012 FY | 15.95 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cosmos Health Inc. | 3.03 Million USD | -19311.295% |
| Safety Shot Inc | 304.9 Thousand USD | -193138.922% |
| Bright Green Corporation | 201.78 Thousand USD | -291896.353% |
| Embecta Corp. | 1.62 Billion USD | 63.751% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | -90.267% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -546.931% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | -20.254% |
| Dynavax Technologies Corporation | 252.41 Million USD | -133.422% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | -17.477% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -4321.424% |
| Pacira BioSciences, Inc. | 513.79 Million USD | -14.676% |
| PainReform Ltd. | 30 Thousand USD | -1963896.667% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -109206.26% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -109206.26% |
| SCYNEXIS, Inc. | 12.15 Million USD | -4745.785% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -502934.261% |
| Journey Medical Corporation | 14.62 Million USD | -3929.538% |
| Alpha Teknova, Inc. | 13.25 Million USD | -4346.449% |
| Procaps Group, S.A. | 28.41 Million USD | -1973.914% |
| Theratechnologies Inc. | 51.26 Million USD | -1049.41% |
| Harrow Health, Inc. | 183.17 Million USD | -221.664% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -677140.23% |
| Biofrontera Inc. | 804 Thousand USD | -73183.458% |
| DURECT Corporation | 2.7 Million USD | -21706.033% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -1674.91% |
| Cronos Group Inc. | 1.55 Million USD | -37693.393% |
| OptiNose, Inc. | 611 Thousand USD | -96331.915% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | -18.24% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -1623.308% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -129394.286% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -869.955% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -4508.826% |
| Radius Health, Inc. | 339.66 Million USD | -73.465% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -5643.8% |
| Phibro Animal Health Corporation | 458.28 Million USD | -28.565% |
| Procaps Group S.A. | 28.41 Million USD | -1973.914% |
| Alvotech | 1.02 Billion USD | 42.672% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -8920.193% |
| Viatris Inc. | 16.18 Billion USD | 96.36% |
| Rockwell Medical, Inc. | 8.29 Million USD | -7004.776% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -5316.926% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -175261.542% |
| Tilray Brands, Inc. | 287.93 Million USD | -104.629% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -388.921% |
| Shineco, Inc. | 10.01 Million USD | -5781.796% |
| PetIQ, Inc. | 437.82 Million USD | -34.576% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -280470.952% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | -128.106% |
| Alimera Sciences, Inc. | 64.48 Million USD | -813.643% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -1429.831% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -436056.164% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -8492.208% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -81733.194% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -2620425.707% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -1698.532% |
| Hempacco Co., Inc. | 5.93 Million USD | -9834.225% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 42.672% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -948.098% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 4.37% |
| Currenc Group, Inc. | 2.5 Million USD | -23402.398% |
| Kamada Ltd. | 7.43 Million USD | -7821.471% |
| Indivior PLC | 235.66 Million USD | -150.014% |
| Evoke Pharma, Inc. | 5 Million USD | -11683.98% |
| Flora Growth Corp. | 942 Thousand USD | -62447.665% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -2620425.707% |
| Evolus, Inc. | 120.35 Million USD | -389.535% |
| HUTCHMED (China) Limited | 48.18 Million USD | -1122.684% |
| Akanda Corp. | 2.49 Million USD | -23494.811% |